© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Intuitive Surgical, Inc. (ISRG) stock declined over -1.30%, trading at $462.26 on NASDAQ, down from the previous close of $468.36. The stock opened at $469.08, fluctuating between $455.35 and $471.50 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 14, 2026 | 459.93 | 471.24 | 459.50 | 467.22 | 1.97M |
| Apr 13, 2026 | 448.17 | 459.25 | 448.17 | 458.96 | 1.69M |
| Apr 10, 2026 | 455.69 | 455.79 | 448.22 | 450.62 | 1.47M |
| Apr 09, 2026 | 459.32 | 460.65 | 451.03 | 454.94 | 1.55M |
| Apr 08, 2026 | 469.99 | 471.98 | 460.24 | 462.28 | 2.25M |
| Apr 07, 2026 | 451.01 | 453.42 | 447.78 | 452.95 | 1.79M |
| Apr 06, 2026 | 451.06 | 458.92 | 449.73 | 452.58 | 1.15M |
| Apr 02, 2026 | 456.26 | 463.93 | 450.40 | 452.07 | 1.64M |
| Apr 01, 2026 | 462.89 | 468.33 | 460.76 | 464.45 | 1.43M |
| Mar 31, 2026 | 455.03 | 463.00 | 448.40 | 460.99 | 1.94M |
| Mar 30, 2026 | 453.05 | 459.00 | 450.27 | 452.78 | 2.19M |
| Mar 27, 2026 | 465.42 | 466.21 | 451.56 | 452.66 | 2.11M |
| Mar 25, 2026 | 474.46 | 480.18 | 468.50 | 469.98 | 1.43M |
| Mar 24, 2026 | 473.75 | 476.13 | 468.36 | 471.91 | 1.23M |
| Mar 23, 2026 | 488.15 | 489.00 | 478.03 | 478.04 | 1.49M |
| Mar 20, 2026 | 480.30 | 484.92 | 473.19 | 477.97 | 2.18M |
| Mar 19, 2026 | 477.50 | 483.04 | 475.81 | 479.93 | 1.25M |
| Mar 18, 2026 | 478.54 | 483.26 | 472.34 | 477.73 | 1.46M |
| Mar 17, 2026 | 487.54 | 494.43 | 482.19 | 482.76 | 1.04M |
| Mar 16, 2026 | 473.32 | 486.13 | 472.95 | 483.46 | 1.3M |
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
| Employees | 15638 |
| Beta | 1.68 |
| Sales or Revenue | $8.35B |
| 5Y Sales Change% | 0.858% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |